I didn’t suggest they were at capacity. The question is whether they moved forward with new treatments such as Excellagen, bringing in techs and trainers, at a time when CV was such an issue.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
